论文部分内容阅读
作者等从1961-1963年期间收治了900例心肌梗死的患者,其中138例(15.3％)出现休克,计男70例,女68例,年龄均在35岁以上。138例中105例有严重休克(收缩压<80),33例中等度休克(收缩压80～90)。采用改善心肌收缩功能与提高血管张力的制剂进行治疗。首先进行解痛,皮下注入1％吗啡1毫升,个别病例无明显效果;此外,给予氧化亚氮吸入麻醉5～10分钟,个别病例达20～30分钟。此外,尚使用氧气吸入疗法。为改善心肌收缩功能,对23例患者(重度11例,中度12例)用毒毛旋花子苷及其衍生物高格利康(Koprлнkoн)和氧气吸入治疗。毒毛旋花子苷一天用0.5～1.0毫克。溶于5％葡萄糖溶液150毫升中作静脉滴注。结果12例中度休克患者全部解除,11例重度患者中2例死亡。
The authors treated 900 patients with myocardial infarction from 1961 to 1963, of whom 138 (15.3%) had shock, 70 males and 68 females, all of whom were over 35 years of age. Of the 138 patients, 105 had severe shock (systolic blood pressure <80) and 33 had moderate shock (systolic blood pressure 80-90). Treatment with agents that improve myocardial contractility and increase vascular tone. The first pain relief, subcutaneous injection of 1% morphine 1 ml, some cases no significant effect; In addition, given nitrous oxide inhalation anesthesia 5 to 10 minutes, some cases up to 20 to 30 minutes. In addition, oxygen inhalation therapy is still used. To improve myocardial contractile function, 23 patients (11 severe and 12 moderate) were treated with poisoned spinosadon and its derivative, Koprлнkoн, and oxygen inhalation. Poisonous hair spinosides with 0.5 to 1.0 mg day. Dissolved in 150 ml of 5% glucose solution for intravenous infusion. Results All 12 moderate shock patients were relieved, and 2 of 11 severe cases died.